- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540157717
3540157719
9780387157719
0387157719
- Maße
-
25 cm
- Umfang
-
XXIV, 741 S.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst.
Literaturangaben
- Erschienen in
-
Handbook of experimental pharmacology ; Vol. 79
- Schlagwort
-
Neuromuskulärer Block
Neuromuskulärer Block
Neuromuskulärer Block
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin, Heidelberg, New York, Tokyo
- (wer)
-
Springer
- (wann)
-
1986
- Urheber
-
Agoston, Sandor
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:19 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Agoston, Sandor
- Charkevič, Dmitrij A.
- Springer
Entstanden
- 1986
Ähnliche Objekte (12)
Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study
Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey
The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials
Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
Basic applied mathematics
Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis
Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study
Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey
The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials
Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
Basic applied mathematics
Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis
Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study
Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey
The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials
Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
Basic applied mathematics